Europe
Four in 10 UK adults would use AI counselling, a global survey suggests, highlighting growing trust in ChatGPT for mental health support. The study, led by Bournemouth University, surveyed nearly 31,000 adults in 35 countries about their use of artificial intelligence large language models such as ChatGPT. It found that 41 per cent of participants [...]
A new Dravet syndrome drug has shown promising results in early clinical trials in children with the rare and hard-to-treat form of epilepsy. Dravet syndrome is a rare genetic disorder that causes severe epilepsy that is often resistant to treatment and can also lead to speech and developmental delays. Around 3,000 people in the UK [...]
Evondos Group, a European health-tech provider transforming home healthcare and the market leader in automated medication dispensing, has announced the appointment of two senior executives. To support rapid growth plans, Tom Ellison will take up the role of Chief Financial Officer (CFO), while Rasmus Platz has been appointed Chief Business Development Officer (CBDO). Ellison has [...]
By Devina Rana, partner at McDermott’s London Real Estate Practice We spend a great deal of time advising private equity sponsors on European real estate transactions from our London office. Over the past few years, one asset class keeps coming back to the table - healthcare real estate. Sometimes the interest is tentative, other times [...]
Delphyr has raised €1.75m to support its artificial intelligence platform designed to reduce the administrative workload faced by healthcare professionals. Founded in 2023, the Amsterdam-based platform supports healthcare professionals in hospitals, primary care and mental health settings with quick search and summary tools. It consolidates patient data from notes, lab results and correspondence into a [...]
A pioneering implantable technology - often described as a ‘sleep apnoea pacemaker’ – has been introduced to the UK, offering an alternative treatment option for people living with moderate-to-severe obstructive sleep apnoea (OSA) who are unable to tolerate conventional therapies such as CPAP. Designed to prevent airway collapse during sleep, the technology works by gently [...]
McDermott Will & Schulte has advised Maire Group on the conclusion and implementation of its joint venture agreements with Newcleo SA. Maire, through its subsidiary Nextchem, and Newcleo SA, an innovative company in the nuclear energy sector co‑founded by Stefano Buono, have completed the establishment of NEXT‑N, a joint venture focused on developing advanced technologies [...]
Magentus, a leading name in clinical diagnostics, announces the formation of a UK Advisory Board to guide the next phase of its strategy and reaffirm its long-term commitment to the UK health system. The announcement marks a significant milestone in Magentus’ renewed leadership in the UK market. It reinforces the company’s focus on earlier diagnosis, [...]
McDermott Will & Schulte has advised Groupe Bruxelles Lambert (“GBL”) in connection with its strategic investment in Rayner, a leading ophthalmic MedTech specialist. GBL has signed definitive agreements to acquire a 45% co‑control stake in Rayner. Under the transaction, GBL will invest €0.5 billion of equity alongside incumbent shareholders, including CVC and the Rayner management [...]
New research from Appian (Nasdaq: APPN) shows the NHS is the most trusted organisation for responsible AI use, ranking higher than any other public or private sector organisation, including banks, retailers, and consumer tech firms. The 2026 UK Public Sector AI Adoption Outlook, conducted by Censuswide on behalf of Appian, polled 1,000 UK public sector workers and [...]
